Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2003 1
2005 1
2007 1
2008 1
2009 1
2010 1
2011 2
2012 6
2013 2
2014 3
2015 1
2016 1
2017 2
2018 1
2019 2
2020 2
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Image-Based Differentiation of Bacterial and Fungal Keratitis Using Deep Convolutional Neural Networks.
Redd TK, Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Venugopal A, Acharya N, Seitzman GD, Lietman TM, Keenan JD, Campbell JP, Song X. Redd TK, et al. Ophthalmol Sci. 2022 Jan 29;2(2):100119. doi: 10.1016/j.xops.2022.100119. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249698 Free PMC article.
CNNs showed relatively higher accuracy for fungal (81%) versus bacterial (75%) ulcers, whereas humans showed relatively higher accuracy for bacterial (88%) versus fungal (56%) ulcers. An ensemble of the best-performing CNN and best-performing human achieved the high …
CNNs showed relatively higher accuracy for fungal (81%) versus bacterial (75%) ulcers, whereas humans showed relatively higher accuracy for …
Glycolipid-Based Oleogels and Organogels: Promising Nanostructured Structuring Agents.
Thamizhanban A, Balaji S, Lalitha K, Prasad YS, Prasad RV, Kumar RA, Maheswari CU, Sridharan V, Nagarajan S. Thamizhanban A, et al. J Agric Food Chem. 2020 Dec 16;68(50):14896-14906. doi: 10.1021/acs.jafc.0c02936. Epub 2020 Dec 7. J Agric Food Chem. 2020. PMID: 33284625
In particular, edible oil structuring using simple amphiphiles would be the best alternative for the currently used trans and saturated fatty acids, which cause deleterious health effects and cardiovascular problems. ...
In particular, edible oil structuring using simple amphiphiles would be the best alternative for the currently used trans and saturat …
Fungal Endophthalmitis: Analysis of 730 Consecutive Eyes from 7 Tertiary Eye Care Centers in India.
Das T, Agarwal M, Anand AR, Behera UC, Bhende M, Das AV, Dasgupta D, Dave VP, Gandhi J, Gunasekaran R, Joseph J, Kulkarni S, Lalitha P, Mahendrakar PA, Mitra S, Mohamed A, Muralidhar A, Nimeshika PL, Prashanthi MTech GS, Sen A, Sharma S, Uday P. Das T, et al. Ophthalmol Retina. 2022 Mar;6(3):243-251. doi: 10.1016/j.oret.2021.09.006. Epub 2021 Sep 20. Ophthalmol Retina. 2022. PMID: 34547530
At least 10% of eyes needed therapeutic keratoplasty, and up to 7% of eyes were eviscerated. After treatment, the final (best corrected) visual acuity (FVA) was >20/400 in 30.5% (n = 222) of eyes and >20/40 in 7.9% (n = 58) of eyes, and 12% (n = 88) of eyes lost ligh …
At least 10% of eyes needed therapeutic keratoplasty, and up to 7% of eyes were eviscerated. After treatment, the final (best correct …
Corticosteroids for bacterial corneal ulcers.
Srinivasan M, Lalitha P, Mahalakshmi R, Prajna NV, Mascarenhas J, Chidambaram JD, Lee S, Hong KC, Zegans M, Glidden DV, McLeod S, Whitcher JP, Lietman TM, Acharya NR. Srinivasan M, et al. Br J Ophthalmol. 2009 Feb;93(2):198-202. doi: 10.1136/bjo.2008.147298. Epub 2008 Oct 1. Br J Ophthalmol. 2009. PMID: 18829631 Free PMC article. Clinical Trial.
All patients received topical moxifloxacin. The primary outcome was best spectacle-corrected visual acuity (BSCVA) at 3 months, adjusting for enrolment BSCVA and arm. ...
All patients received topical moxifloxacin. The primary outcome was best spectacle-corrected visual acuity (BSCVA) at 3 months, adjus …
Nocardia keratitis: clinical course and effect of corticosteroids.
Lalitha P, Srinivasan M, Rajaraman R, Ravindran M, Mascarenhas J, Priya JL, Sy A, Oldenburg CE, Ray KJ, Zegans ME, McLeod SD, Lietman TM, Acharya NR. Lalitha P, et al. Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5. Am J Ophthalmol. 2012. PMID: 22959881 Free PMC article. Clinical Trial.
METHODS: setting: Multicenter randomized controlled trial. study population: Five hundred patients with bacterial keratitis randomized 1:1 to topical corticosteroid or placebo who had received at least 48 hours of topical moxifloxacin. intervention/observation procedure: Topical …
METHODS: setting: Multicenter randomized controlled trial. study population: Five hundred patients with bacterial keratitis randomized 1:1 t …
The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
Ray KJ, Prajna NV, Lalitha P, Rajaraman R, Krishnan T, Patel S, Das M, Shah R, Dhakhwa K, McLeod SD, Zegans ME, Acharya NR, Lietman TM, Rose-Nussbaumer J; Mycotic Ulcer Treatment Trial Group. Ray KJ, et al. Am J Ophthalmol. 2018 May;189:41-46. doi: 10.1016/j.ajo.2018.02.003. Epub 2018 Feb 10. Am J Ophthalmol. 2018. PMID: 29438654 Free PMC article. Clinical Trial.
MAIN OUTCOME MEASURES: The primary outcome is rate of corneal perforation and/or the need for therapeutic penetrating keratoplasty. Secondary outcomes include 3-month best spectacle-corrected visual acuity (BSCVA), 3-month infiltrate and/or scar size, and rate of re-epithe …
MAIN OUTCOME MEASURES: The primary outcome is rate of corneal perforation and/or the need for therapeutic penetrating keratoplasty. Secondar …
In silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitus.
Rajalakshmi R, Lalitha P, Sharma SC, Rajiv A, Chithambharan A, Ponnusamy A. Rajalakshmi R, et al. J Mol Recognit. 2021 Nov;34(11):e2925. doi: 10.1002/jmr.2925. Epub 2021 Jul 24. J Mol Recognit. 2021. PMID: 34302410
The results indicate that the drug likeliness of the molecule 4, that is, N-[(3,3-dimethyl piperidin-2-yl) methyl]-4-ethyl sulphonyl aniline is active with decreasing binding energy score (-212.24 Kcal mol(-1) ) with no toxicity and also few sulphur compounds are active against d …
The results indicate that the drug likeliness of the molecule 4, that is, N-[(3,3-dimethyl piperidin-2-yl) methyl]-4-ethyl sulphonyl aniline …
Mediators of the Effect of Corneal Cross-Linking on Visual Acuity for Fungal Ulcers: A Prespecified Secondary Analysis From the Cross-Linking-Assisted Infection Reduction Trial.
Prajna NV, Radhakrishnan N, Lalitha P, Liu Z, Keenan JD, Arnold BF, Rose-Nussbaumer J. Prajna NV, et al. Cornea. 2022 Oct 1;41(10):1217-1221. doi: 10.1097/ICO.0000000000002965. Epub 2022 Jan 17. Cornea. 2022. PMID: 35044972 Clinical Trial.
The treatment arms included (1) topical natamycin 5% alone, (2) topical natamycin 5% plus CXL, (3) topical amphotericin B 0.15% alone, and (4) topical amphotericin 0.15% plus CXL. Best spectacle-corrected visual acuity (BSCVA), contact lens over-refraction, and scar size a …
The treatment arms included (1) topical natamycin 5% alone, (2) topical natamycin 5% plus CXL, (3) topical amphotericin B 0.15% alone, and ( …
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10. Arch Ophthalmol. 2012. PMID: 21987582 Free PMC article. Clinical Trial.
Eligible patients had a culture-positive bacterial corneal ulcer and received topical moxifloxacin for at least 48 hours before randomization. MAIN OUTCOME MEASURES: The primary outcome was best spectacle-corrected visual acuity (BSCVA) at 3 months from enrollment. ...
Eligible patients had a culture-positive bacterial corneal ulcer and received topical moxifloxacin for at least 48 hours before randomizatio …
The steroids for corneal ulcers trial: study design and baseline characteristics.
Srinivasan M, Mascarenhas J, Rajaraman R, Ravindran M, Lalitha P, Glidden DV, Ray KJ, Hong KC, Oldenburg CE, Lee SM, Zegans ME, McLeod SD, Lietman TM, Acharya NR; Steroids for Corneal Ulcers Trial Group. Srinivasan M, et al. Arch Ophthalmol. 2012 Feb;130(2):151-7. doi: 10.1001/archophthalmol.2011.303. Epub 2011 Oct 10. Arch Ophthalmol. 2012. PMID: 21987581 Free PMC article. Clinical Trial.
Eligible patients had a culture-positive bacterial corneal ulcer and had been taking moxifloxacin for 48 hours. The primary outcome for the trial is best spectacle-corrected visual acuity at 3 months from enrollment. This report provides comprehensive baseline data, includ …
Eligible patients had a culture-positive bacterial corneal ulcer and had been taking moxifloxacin for 48 hours. The primary outcome for the …
30 results